Sarcura: Can deep tech be utilized to enhance cell therapy manufacturing?
Austian start-up Sarcura has secured a €1.7 million grant to help the company develop a ‘miniaturized and autonomous’ cell therapy manufacturing platform using deep tech.
Archives for March 11, 2024
How fibrinolytic biomarkers could transform the way we approach severe COVID-19
One of the most challenging aspects of the COVID-19 pandemic was not being able to assess how individual patients would respond to the virus and how severe their symptoms would be.